PMDA — authorised 7 May 2020
- Marketing authorisation holder: Gilead Sciences K.K.
- Status: approved
PMDA authorised Veklury on 7 May 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 7 May 2020.
Gilead Sciences K.K. holds the Japanese marketing authorisation.